Fundraising Fox
DAMONA Pharmaceuticals
4 employees on LinkedIn · 4 known investors
Find your way into DAMONA Pharmaceuticals
Sign up to find every way you can get introduced to DAMONA Pharmaceuticals
- Your email: who you already know at DAMONA Pharmaceuticals, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the DAMONA Pharmaceuticals team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Damona develops precision neuromedicines aimed at treating cognitive deficits associated with neurodegenerative and psychiatric disorders such as Alzheimer's disease, depression, and schizophrenia. Its lead drug targets a specific subunit of the GABA-A receptor to improve neuronal function and reverse cognitive impairment.
Investors · 4
Related companies · 5
Day One BiopharmaceuticalsDay One is a biopharmaceutical company that develops first- or best-in-class targeted medicines for children and adults with life-threatening diseases, with a focus on cancers such as pediatric brain tumors. Founded in 2018, it received its first FDA approval in 2024 for a pediatric brain tumor treatment.
BioworldBioWorld is a suite of daily news and data services covering therapeutics, medical technology, biopharma business transactions, and drug R&D, serving biopharmaceutical and medtech industry professionals. Owned by Clarivate, it publishes products including BioWorld, BioWorld Science, and BioWorld Asia with reporting from writers stationed globally.
Muna TherapeuticsMuna Therapeutics is a biotechnology company developing therapeutics, with a focus on drug discovery involving medicinal chemistry.
InspirnaInspirna is a clinical-stage biopharmaceutical company developing novel cancer drugs that target previously undruggable drivers of metastasis using its proprietary miRNA-DRIVEr platform. The company focuses on common cancers with high unmet need through small molecules and biologics.
ModernaModerna develops mRNA-based medicines for infectious and serious diseases using its proprietary mRNA platform and design technology.
Companies working in the same space as DAMONA Pharmaceuticals.
Frequently asked questions
- What does DAMONA Pharmaceuticals do?
- Damona develops precision neuromedicines aimed at treating cognitive deficits associated with neurodegenerative and psychiatric disorders such as Alzheimer's disease, depression, and schizophrenia. Its lead drug targets a specific subunit of the GABA-A receptor to improve neuronal function and reverse cognitive impairment.
- Who are DAMONA Pharmaceuticals's investors?
- DAMONA Pharmaceuticals's investors include Angelini Ventures, Lumira Ventures, Noetic, Toronto Innovation Acceleration Partners.